Short answer · Medically reviewed summary · Last updated: 2026-05-08
Rasmussen's encephalitis was first described in 1958 by neurologist Theodore Rasmussen, who identified it as a rare, chronic inflammatory brain disorder characterized by drug-resistant focal seizures and progressive neurological decline. While originally thought to be a slow-growing viral infection, modern research has shifted our understanding of Rasmussen's encephalitis toward an immune-mediated process involving T-cell-driven destruction of brain tissue. How was Rasmussen's encephalitis first discovered? In 1958, Dr.
What is the history of Rasmussen's encephalitis?
History of Rasmussen's encephalitis: when and how it was discovered, and the milestones in research since, medically reviewed.
Rasmussen's encephalitis was first described in 1958 by neurologist Theodore Rasmussen, who identified it as a rare, chronic inflammatory brain disorder characterized by drug-resistant focal seizures and progressive neurological decline. While originally thought to be a slow-growing viral infection, modern research has shifted our understanding of Rasmussen's encephalitis toward an immune-mediated process involving T-cell-driven destruction of brain tissue.
How was Rasmussen's encephalitis first discovered?
In 1958, Dr. Theodore Rasmussen and his colleagues at the Montreal Neurological Institute published a landmark paper describing three children with chronic focal seizures and progressive hemiparesis. At the time, the etiology of Rasmussen's encephalitis was a mystery, leading clinicians to classify it as "chronic encephalitis." For decades, researchers searched for a causative virus, but consistent evidence remained elusive, leaving patients and families with limited answers.
How has our understanding of the disease evolved?
The medical community’s perspective on Rasmussen's encephalitis has undergone a significant paradigm shift. Through the late 20th century, the focus moved from viral hypotheses to autoimmune mechanisms. Today, Rasmussen's encephalitis is widely understood as a localized autoimmune condition where cytotoxic T-cells specifically target and destroy astrocytes and neurons in one hemisphere of the brain.
What are the major milestones in treatment history?
Treatment for Rasmussen's encephalitis has evolved from basic supportive care to aggressive surgical intervention. Key milestones include:
- 1970s-1980s: Emergence of functional hemispherectomy as the gold standard for stopping seizures.
- 1990s: Introduction of immunotherapy (IVIG, steroids) to attempt to slow the disease's progression.
- Modern Era: Refinement of surgical techniques, such as peri-insular hemispherotomy, which reduces surgical morbidity.
How has technology changed the diagnosis?
Technological advancements, particularly high-resolution MRI and PET imaging, have revolutionized the early detection of Rasmussen's encephalitis. These tools allow clinicians to visualize the characteristic unilateral hemispheric atrophy long before it becomes clinically obvious, enabling earlier intervention for the 14 community members and others currently living with this condition.
Next steps
- Consult a pediatric or adult neurologist specializing in refractory epilepsy.
- Connect with the 14 members of the DiseaseMaps.org community to share lived experiences.
- Discuss current clinical trials regarding immunotherapy with your neuro-immunology team.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Rasmussen's Encephalitis
- Orphanet: Rare Disease Database (ORPHA: 2908)
- The Montreal Neurological Institute and Hospital: History of Epilepsy Research
- PubMed/NCBI: Review of the immunopathology of Rasmussen's encephalitis
